Osavampator

Chemical compound

Osavampator (developmental code names TAK-653 and NBI-1065845) is an experimental drug being investigated as a treatment for treatment-resistant depression. It is being developed by Neurocrine Biosciences and Takeda Pharmaceuticals (Millennium Pharmaceuticals, Inc.).

Nº Q116977443 ★

Común · Saberes

Osavampator

Chemical compound

Texto en inglés

Osavampator (developmental code names TAK-653 and NBI-1065845) is an experimental drug being investigated as a treatment for treatment-resistant depression. It is being developed by Neurocrine Biosciences and Takeda Pharmaceuticals (Millennium Pharmaceuticals, Inc.).

En Wikipedia

Texto en inglés Aún no hay artículo en tu idioma: extracto en inglés.

Osavampator (developmental code names TAK-653 and NBI-1065845) is an experimental drug being investigated as a treatment for treatment-resistant depression. It is being developed by Neurocrine Biosciences and Takeda Pharmaceuticals (Millennium Pharmaceuticals, Inc.). Takeda Pharmaceuticals discovered the molecule originally, and holds exclusive right to market the drug in Japan, while Neurocrine Biosciences holds the right to market it to the rest of the world.

Texto: Wikipedia en inglés, CC BY-SA 4.0. · Imagen: User:Innerstream (Public domain) ·

Cartas cercanas

Abrir

…

Confirmación